USPTO serial 87505428
CUREMARK DIAGNOSTICS
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- LAVACHE, LINDA M
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with CUREMARK DIAGNOSTICS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Nicole K. McLaughlin
Nicole K. McLaughlin DUANE MORRIS LLP30 S. 17TH ST.PHILADELPHIA, PA 19103-4196UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Assays and reagents for use in medical research; biological substances, namely, urine, blood, feces, saliva, and lymph for scientific and medical research use; biological preparations for research purposes and for scientific testing; chemical preparations for scientific and research purposes | ACTIVE | — |
| 005 | Biological preparations for medical testing, namely, biological preparations for the treatment of neurodegenerative diseases, neurological disorders, schizophrenia and schizoform disorders, autism and autism spectrum disorders, disorders of the autonomic nervous system, pancreatic deficiencies, gastrointestinal disease, intestinal malabsorption syndromes, ADHD, William's syndrome, addictive disorders; pharmaceutical preparations, namely, enzymes, hormones and other biologicals, namely, neurotransmitter substances and immunological markers used to diagnose neurological diseases; diagnostic preparations for medical purposes; testing kits comprised of medical diagnostic reagents and assays for testing enzymes and body fluids for use in disease detection, namely, neurodegenerative diseases, neurological disorders, schizophrenia and schizoform disorders, autism and autism spectrum disorders, disorders of the autonomic nervous system, pancreatic deficiencies, gastrointestinal disease, intestinal malabsorption syndromes, ADHD, William's syndrome, addictive disorders; medical diagnostic reagents and assays for testing of enzymes and body fluids; chemical preparations for medical testing, namely, for neurodegenerative diseases, neurological disorders, schizophrenia and schizoform disorders, autism and autism spectrum disorders, disorders of the autonomic nervous system, pancreatic deficiencies, gastrointestinal disease, intestinal malabsorption syndromes, ADHD, William's syndrome, addictive disorders | ACTIVE | — |
| 042 | Design, development and administration of assays, namely, diagnostic assessment on bodily fluids for detection and determination of therapy for neurodegenerative diseases, neurological disorders, schizophrenia and schizoform disorders, autism and autism spectrum disorders, disorders of the autonomic nervous system, pancreatic deficiencies, gastrointestinal disease, intestinal malabsorption syndromes, ADHD, William's syndrome, addictive disorders, for the detection of enzymes or biological substances in humans; medical and scientific research services in the field of digestion and detection of enzymes or biological substances in the body | ACTIVE | — |
| 044 | Medical consultations; medical testing for diagnostic or treatment purposes in the field of neurodegenerative diseases, neurological disorders, schizophrenia and schizoform disorders, autism and autism spectrum disorders, disorders of the autonomic nervous system, pancreatic deficiencies, gastrointestinal disease, intestinal malabsorption syndromes, ADHD, William's syndrome, addictive disorders; medical diagnostic testing, monitoring and reporting services; performing diagnosis of diseases | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Curemark Diagnostics LLC
- Other trademarks owned by Curemark Diagnostics LLC
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named CUREMARK DIAGNOSTICS
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 23, 2021 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Aug 23, 2021 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jan 1, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Dec 31, 2020 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Dec 31, 2020 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Dec 11, 2020 | EXT5 | SOU EXTENSION 5 FILED | — |
| Dec 11, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Sep 25, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 24, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jun 22, 2020 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Jun 22, 2020 | EXT4 | SOU EXTENSION 4 FILED | — |
| Jun 22, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 27, 2019 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Nov 25, 2019 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Nov 25, 2019 | EXT3 | SOU EXTENSION 3 FILED | — |
| Nov 25, 2019 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 7, 2019 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jun 5, 2019 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Jun 5, 2019 | EXT2 | SOU EXTENSION 2 FILED | — |
| Jun 5, 2019 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 5, 2019 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 3, 2019 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jan 3, 2019 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jan 3, 2019 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 17, 2018 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| May 22, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 22, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 2, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 12, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 10, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 9, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 9, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 10, 2017 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 10, 2017 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 10, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 22, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 1, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 29, 2017 | NWAP | NEW APPLICATION ENTERED | — |